Skip to main content

Table 3 Annual average direct costs by number of headache days per month

From: Economic consequences of migraine in Sweden and implications for the cost-effectiveness of onabotulinumtoxinA (Botox) for chronic migraine in Sweden and Norway

Headache days per month

Direct costs (EUR)

Healthcare utilization

Drug treatments

Total

0–4 headache days

805

311

1116

5–9 headache days

1707

660

2368

10–14 headache days

1500

1181

2681

15–24 headache days

2312

1697

4009

25–31 headache days

2942

2370

5311